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Background: Exposure of animals to hyperoxia causes lung injury, characterized by diffuse
alveolar damage and exudation of plasma into the alveolar space. Reactive oxygen species
(ROS) play an important role in the development of hyperoxic lung injury. Mitochondrial
oxidative phosphorylation is one of the major sources of ROS. N-acetylcysteine (NAC) is a
precursor of glutathione (GSH), which functions as an antioxidant by reducing hydrogen
peroxide to water and alcohols. NAC has been shown to diminish lung injury in a large
variety of animal models.
Aim: We elucidated the mechanism underlying the protective effects of NAC in hyperoxia-
induced lung injury.
Methods: Male BALB/c mice were exposed to 98% oxygen for 72 h. The mice inhaled NAC
or saline twice a day from 72 h before oxygen exposure to the end of experiment.
Results: Inhaled NAC increased the GSH level in lung homogenate. NAC also attenuated
cellular infiltrations in both bronchoalveolar lavage fluid (BALF) and lung tissue. The total
protein level in BALF and the level of 8-isoprostane, a marker of lipid peroxidation, in lung
homogenate were decreased by inhalation of NAC. Inhaled NAC induced the overexpression
of Mn superoxide dismutase (MnSOD) mRNA and protein, but did not alter the expressions
of other antioxidant enzymes, including CuZnSOD, extracellular SOD, and glutathione
peroxydase 1.
Conclusion: These findings suggest that the antioxidant properties of NAC in hyperoxic
lung injury involve a decrease in mitochondrial ROS in association with the induction of
MnSOD, in addition to its role as a precursor of GSH.
& 2006 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
251 5511; fax: +81 75 251 5514.
.ac.jp.
ARTICLE IN PRESS
Overexpression of manganese superoxide dismutase by N-acetylcysteine in hyperoxic lung injury 801Introduction
High oxygen concentrations are commonly used to treat
critically ill patients who have respiratory failure. However,
prolonged exposure to hyperoxia causes tissue injury.1,2
Exposure of normal animals to pure oxygen for 48–72 h
causes respiratory failure and death.3 Examination of the
lungs after prolonged exposure to oxygen reveals diffuse
alveolar damage and exudation of plasma into the alveolar
space.4 Increased production of reactive oxygen species
(ROS) such as superoxide, hydroxyl radicals, and hydrogen
peroxide are generally considered essential for oxygen
toxicity.5–8 Hyperoxia-induced increases in the intracellular
production of ROS are thought to depend on mitochondria.
Therefore, many studies have attempted to prevent
hyperoxic lung injury by reducing ROS production by
mitochondria.
The glutathione (GSH) pathway is one of the most
important mechanisms for protecting cells and tissues from
ROS. GSH acts as a radical scavenger by reacting with
hydrogen peroxide to form water and alcohol, a reaction
catalyzed by glutathione peroxidase. N-acetylcysteine
(NAC) is a precursor of GSH. Treatment with NAC has been
shown to ameliorate tissue injury in many animal models.
NAC also can directly scavenge oxygen free radicals.9–11
Moreover, it regulates the production of some cytokines or
the expression of adhesion molecules on endothelial cells
and bronchial epithelial cells. However, the mechanism by
which NAC protects against lung injury remains to be fully
elucidated. NAC has been reported to be effective in various
models of lung injury. Das et al.12 have reported that thiol
reducing agents such as NAC activate NF-kB and increase the
Mn superoxide dismutase (MnSOD) expression in pulmonary
A549 cells. Hagiwara et al.13 reported that aerosol admin-
istration of NAC significantly elevates GSH in bronchoalveo-
lar lavage fluid (BALF) and attenuates inflammation and lung
fibrosis in bleomycin-induced lung injury.
Superoxide dismutase (SOD) catalyzes the conversion of
superoxide anions to hydrogen peroxide and water. Three
isoforms of SOD have been found in mammalian cells:
CuZnSOD, MnSOD, and extracellular SOD (ecSOD). CuZnSOD
and MnSOD are generally thought to act as bulk scavengers
of superoxide radicals. CuZnSOD, which is mainly a cytosolic
enzyme, is evenly distributed intracellularly but is also
found in the nucleus and lysosomes. It is expressed in the
bronchial epithelium of human lung, and in the alveolar
epithelium, mesenchymal cells, fibroblasts, and vascular
endothelial cells in rat lungs.14 ecSOD is primarily localized
to the extracellular matrix.15 It has also been detected in
the bronchial epithelium, alveolar epithelium, and alveolar
macrophages. MnSOD inactivates mitochondrial ROS. Studies
using exogenous MnSOD or genetically altered mice over-
expressing MnSOD have shown that MnSOD ameliorates
hyperoxic lung injury.16 To our knowledge, however, no
previous study has examined the effect of NAC on the
expression of MnSOD in hyperoxic lung injury. We tested the
hypothesis that treatment with NAC protects against
hyperoxic lung injury due to mitochondrial ROS production
by inducing the overexpression of MnSOD, in addition its role
as a precursor of GSH. We examined the mRNA expressions
of antioxidant enzymes such as MnSOD, CuZnSOD, ecSOD,
and glutathione peroxidase 1 (GPx1). Furthermore, theprotective effects of NAC on hyperoxic lung injury were
evaluated on the basis of histological examination and
various indices of lung injury.
Material and methods
Animals
These experiments were approved by the Institutional
Animal Care and Use Committee of Kyoto Prefectural
University of Medicine. Specific pathogen-free BALB/c mice
(5- to 6-week-old males) [Japan SLC, Kyoto, Japan] were
used in all experiments. All mice were housed in the animal
care facility at Kyoto Prefectural University of Medicine until
the end of the experiments.
Oxygen exposure
Mice were exposed to 98% oxygen for 72 h in a sealed
Plexiglas chamber and the fractional inspired O2 concentra-
tion in the chamber was monitored with an oxygen analyzer
as described in Barazzone et al.17 Mice exposed to room air
under the same conditions served as control. Food and water
were available ad libitum.
NAC preparation and administration
N-acetyl-L-cysteine (Nacalai Tesque, Kyoto, Japan) was
dissolved in saline at a concentration of 70mg/ml and
neutralized at pH 7.0. Thirty milliliters of NAC solution or
saline, delivered by an ultrasonic nebulizer, was inhaled for
10min twice a day in the chamber. The inhalation was
started 3 days before exposure to pure oxygen.
Bronchoalveolar lavage (BAL)
BAL was performed by administration of 0.5ml of sterile
saline solution three times, and the total cell counts in BAL
fluid (BALF) were determined with a hemocytometer.
Differential cell counts were determined with the use of
cytospin preparations stained with Giemsa-type stain. The
BALF was centrifuged at 500g for 10min at 4 1C, and the
total protein concentration in BALF supernatant was
determined by the Bradford method.
GSH analysis
To measure total GSH, lungs were frozen in liquid nitrogen
and homogenized with 0.1M phosphate buffer (pH 7.4)
containing 5% sulfosalicylic acid. The homogenate was
centrifuged at 8000g for 10min. GSH in supernatant was
measured with the use of a total Glutathione Quantification
Kit (Dojindo Laboratories, Kumamoto, Japan).
Protein extraction
Lungs were frozen in liquid nitrogen and homogenized
with 2.0ml of lysis buffer (10mmol/l Tris-HCl, pH
7.4, 150mmol/l NaCl, 25mmol/l EDTA, 5mmol/l EGTA,
0.25% sodium deoxycholate, 1mmol/l DTT, 0.1mg/ml PMSF,
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Figure 1 GSH concentration in lung. The values represent the
means7SEM derived from four animals in each group (*Po0.05,
**Po0.01).
K. Nagata et al.8022mg/ml leupeptin). The homogenate was centrifuged at
15,000g for 10min.
Lipid peroxidation
8-Isoprostane was measured using an 8-Isoprostane EIA Kit
(Cayman Chemical Company, Ann Arbor, MI) according to the
manufacturer’s instructions.
Western blotting for MnSOD
To identify MnSOD, western blotting was performed with the
use of a rabbit anti-MnSOD polyclonal antibody against
mouse MnSOD (Stressgen, Victoria, BC, Canada). Twenty
micrograms of proteins were subjected to SDS-PAGE analy-
sis, followed by immunoblotting with anti-MnSOD antibody.
The immunoreactive MnSOD proteins were visualized using
enhanced chemiluminescence (Amersham Bioscience, Pis-
cataway, NJ, USA), according to the manufacturer’s instruc-
tions.
RNA isolation and reverse transcription
Total RNA samples from lung tissues were isolated with the
use of an RNeasy RNA extraction kit (Qiagen K.K., Tokyo,
Japan) according to the manufacturer’s protocol. First-
strand cDNA was synthesized with 2mg of total RNA as a
template, using a SuperScript First-Strand Synthesis System
(Incitrogen, Carlsbad, CA, USA).
Real-time PCR
Quantitative PCR was performed using a LightCycler instru-
ment (Roche Diagnostics) with 20ml of LightCycler DNA-
Master, SYBR Green I, 25 pmol of oligonucleotide primers,
2ml of cDNA solution, and 2.4ml of 25mmol/l MgCl2. After
initial denaturation at 95.8 1C for 10min, reactions were
cycled 40 times under the following conditions to detect b-
actin, CuZnSOD, MnSOD, ecSOD, and GP 1: 95.8 1C for 5 s,
primer annealing at 58.8 1C for 10 s, and primer extension at
72.8 1C for 20 s. Specific oligonucleotide primer sequences
were as follows. For mouse b-actin, forward: 50-GGCCAGGT-
CATCACTATTG-30; reverse: 50-GAGGTC TTTACGGATGTCAAC-
30 (amplifies a fragment of 147 bp). For mouse CuZnSOD,
forward: 50-GACAAACCTGAGCCCTAAG-30; reverse: 50-CGACC
TTGCTCCTTATTG-30 (amplifies a fragment of 168 bp). For
mouse MnSOD, forward: 50-ATGTCTGTGGGAGTCCAA-30; re-
verse: 50-TGAAGGTAGTAAGCGTGCTC-3’ (amplifies a frag-
ment of 164 bp). For mouse ecSOD, forward: 50-ATTT
CAGTCTGGAGGGCT-30; reverse: 50-CACGAAGTTGCCAAAG
TC-30 (amplifies a fragment of 164 bp). For mouse GPx1,
forward: 50-GACTACACCGAGATGAACGAT-30; reverse: 50-CACT
TCGCACTTCTCAAACA-30 (amplifies a fragment of 189 bp).
SYBR Green I fluorescence was detected at the end of
each cycle to monitor the amount of PCR product formed
during the cycle. At the end of each run, melting
curve profiles were produced to confirm amplification of
specific transcripts. Cycle-to-cycle fluorescence emission
readings were monitored and quantified using the second
derivative maximum method with LightCycler Software(Roche Molecular Biochemicals). Standard curves for b-actin
and other primers were constructed using a serial dilution of
total cDNA. All calculated concentrations are relative to the
concentration of the standard.
Histologic examination of lung
The lungs were inflated by administration of 0.5ml of 4%
paraformaldehyde. For hematoxylin–eosin staining, the
lungs were removed en bloc and placed in 4% paraformal-
dehyde overnight. After fixation, the lungs were embedded
in paraffin and cut to a thickness of 4mm. They were then
stained with hematoxylin–eosin.
Statistical analyses
All data, expressed as means7SE, were analyzed by one-way
analysis of variance. The statistical significance of differ-
ences between groups was assessed by the Fisher protected
least-significant difference test; Po0.05 was considered to
indicate statistical significance.
Results
Lung GSH analysis
To assess the effect of aerosolized NAC, we measured GSH in
lung homogenate (Fig. 1). After exposure to 98% oxygen, the
GSH levels of mice treated with NAC were significantly
higher than those of mice not treated with NAC.
Histopathologic changes
To elucidate the protective effect of NAC on hyperoxic lung
injury, we compared the microscopic features of lungs after
exposure to 98% oxygen with or without NAC treatment
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Figure 2 Histopathologic changes after exposure to hyperoxia for 72 h.
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large amounts of alveolar exudates and inflammatory cell
infiltrates in the interstitium and airspace. Alveolar hemor-
rhage was also seen. NAC treatment markedly diminished
the alveolar exudates and inflammatory cell infiltrates in
hyperoxic lung injury.2.0
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Figure 3 BALF protein content. The values represent the
means7SEM derived from six animals in each group (*Po0.05,BALF analysis
Exposure to 98% oxygen significantly increased total protein
in BALF (Fig. 3). This response was significantly inhibited by
inhalation of NAC. After exposure to 98% oxygen, the total
protein level in BALF was 2.3570.09mg/ml in the oxygen
group and 1.7570.3mg/ml in the NAC group (Po0.05).
Total cell counts, alveolar macrophage counts, and
neutrophil counts in BALF increased after exposure to 98%
oxygen. NAC treatment significantly inhibited these oxygen-
induced increases (Po0.05). NAC had no effect on lympho-
cyte counts in hyperoxic lung injury (Fig. 4).**Po0.01).Lipid peroxidation
8-Isoprostane is one of the most reliable biomarkers of lipid
peroxidation and oxidative stress. The level of 8-isoprostane
was significantly increased after 72 h of exposure to 98%
oxygen. Aerosol NAC significantly inhibited lipid peroxida-
tion in lung after 72 h of exposure to 98% oxygen (142 pg/mg
of protein vs. 228 pg/mg of protein, Po0.05) (Fig. 5).RT-PCR of lung homogenates
To evaluate the role of NAC as an antioxidant, apart from its
role as a precursor of GSH, we measured the mRNA
expression of MnSOD, CuZnSOD, ecSOD, and GPx1 (Fig. 6).
These enzymes scavenge ROS production. NAC significantly
increased the MnSOD mRNA level, but did not alter the
mRNA levels of other antioxidant enzymes, including
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Figure 4 Cell differentiation in BALF. The values represent the means7SEM derived from six animals in each group (*Po0.05).
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Figure 5 Lipid peroxidation in lung. The values represent the
means7SEM derived from four animals in each group (*Po0.05,
**Po0.01).
K. Nagata et al.804CuZnSOD, ecSOD, and GP 1. The time course of the MnSOD
mRNA after the exposure of 98% oxygen is shown in Fig. 7.
After 3 days treatment of NAC, the expression of MnSOD
mRNA before oxygen exposure was significantly higher than
that without NAC. The expressions of MnSOD mRNA after
oxygen exposure were gradually increased in both groups.
Hyperoxia induced the significant increase of MnSOD mRNA
in both groups. The time course of MnSOD mRNA in the NAC-
treated mice did not change under the normoxic condition
(data not shown).Western blotting for MnSOD
After 3 days treatment of NAC, MnSOD protein before
oxygen exposure was significantly higher than that without
NAC (2.470.5 versus 1.070.2: Po0.01). Seventy-two hours
after exposure of hyperoxia, MnSOD protein in NAC-treated
mice was significantly higher than that in the group without
NAC treatment (3.170.1 versus 2.270.4) (Fig. 8).Discussion
Hyperoxic lung injury is histologically characterized by
extensive alveolar damage, leading to the disruption of
the alveolar-capillary barrier and pulmonary edema.4
Inflammatory cells such as alveolar macrophages, neutro-
phils, and platelets accumulate in alveolar space and
interstitium.18,19 ROS is generated in a variety of cells,
including alveolar epithelial cells, inflammatory cells, and
endothelial cells. Oxygen-induced lung injury is generally
considered to result from the direct action of increased
ROS.5–7 During exposure to oxygen, increased ROS produc-
tion is thought to depend on mitochondria.20,21 Overproduc-
tion of superoxide has been specifically detected in rat lung
mitochondria and submitochondrial particles.20,22 Produc-
tion of ROS is associated with the increased release of
hydrogen peroxide by lung mitochondria and microsomes.23
Our study showed that alveolar exudates and inflammatory
cell infiltrates increased in both the lung tissue and BALF
after 72 h of exposure to oxygen. We evaluated the lipid
peroxidation product 8-isoprostane as a marker of oxidant-
stress. After 72 h of exposure to oxygen, 8-isoprostane in the
lung tissue increased significantly. Inhalation of NAC
attenuated inflammatory cell infiltration and 8-isoprostane
production and reduced oxidative stress associated with
hyperoxic lung injury. The GSH pathway and SOD pathway
constitute the principal known routes for protection against
ROS in the lung.24,25 We therefore investigated the effect of
NAC on these antioxidative pathways in hyperoxic lung
injury.
GSH is a potent intracellular scavenger and could only
decrease the level of oxidative stress. GSH converts
hydrogen peroxide to alcohol and water. However, admin-
istration of GSH to animals produces low concentrations of
GSH in tissue, and the antioxidant properties of GSH are
difficult to demonstrate in vivo. In contrast, administration
of NAC maintains adequate tissue concentrations of GSH,
permitting assessment of its antioxidant properties. NAC has
been used clinically to treat hepatic injury caused by an
overdose of acetaminophen or carbon tetrachloride poison-
ing.26 Experimentally, treatment with NAC has been shown
to ameliorate tissue injury in various models of lung injury.
In hyperoxic lung injury, ROS is generated in a variety of
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Figure 6 Quantification of anti-oxidative enzyme mRNAs in lung. The values represent the means+SEM derived from four animals in
each group (*Po0.05).
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Figure 8 Western blot analysis for the detection of MnSOD in
lung. Quantification of four different samples for each group
was performed by scanning densitometry. The values represent
means7SEM (*Po0.05, **Po0.01).
Overexpression of manganese superoxide dismutase by N-acetylcysteine in hyperoxic lung injury 805cells in alveolar spaces. Since the lung is exposed to the
highest concentration of oxygen, one strategy to prevent
lung injury is to increase the concentration of antioxidants
in the lung. Administration of aerosolized NAC may maintain
a higher concentration of NAC in the lung than that
obtainable by systemic administration. In our study, aero-
solized NAC was administered as described by Hagiwaraet al.,13 who found that the GSH concentration in BALF
peaked 3 days after the initiation of NAC inhalation. We
therefore started exposure to hyperoxia at this time. Our
results showed that hyperoxia increased GSH concentrations
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K. Nagata et al.806in the lung. This increase in GSH is caused by induction of
g-glutamyl cysteine synthetase, the rate-limiting enzyme
in GSH synthesis, under the oxidative stress.11,27 The
increase in GSH is insufficient to compensate the
oxidative stress from hyperoxia. Aerosolized NAC signifi-
cantly increased the GSH concentration in the lung after
exposure to hyperoxia, and resulted the reduction of
oxidative stress.
Animal and human studies have suggested that acute and
chronic lung injury due to hyperoxia may be ameliorated by
the administration of antioxidants, specifically SOD.28–32
Three isoforms of SOD have been found in mammalian cells:
CuZnSOD, MnSOD, and ecSOD. These isoforms have specific
distributions: CuZnSOD is found in the cytosol and peroxi-
somes, MnSOD in mitochondria, and ecSOD in extracellular
fluids. Koo et al.33 have reported that alveolar epithelial
cells overexpressing MnSOD and GPx are protected against
mitochondrial oxidation due to hyperoxia. They have also
demonstrated that combined application of MnSOD and GPx
provides optimal protection from hyperoxic lung injury, as
compared with the effects of other combinations of
antioxidants. Overexpression of MnSOD has been shown to
improve the survival of transgenic mice exposed to 95%
oxygen, whereas overexpression of CuZnSOD or ecSOD does
not prevent hyperoxic lung injury.34 These results suggest
that mitochondrial ROS production plays a critical role in
hyperoxic lung injury and that MnSOD reduces lung injury by
decreasing mitochondrial ROS production.
MnSOD is highly responsive multiple extracellular stimuli
including cytokines, oxidants and radiation, and this induc-
tion is thought to have physiological significance, especially
in the protection of alveolar epithelium.35 However, the
regulation of MnSOD gene expression is not well under
stood. Das et al. have reported that thiol reducing agents
such as NAC can activate NF-kB and increase MnSOD
mRNA in pulmonary A549 cells in the steady state. Thiol
reducing agents augment the effects of both TNF-a and IL-1b
in causing activation of NF-kB and elevated MnSOD gene
expression.12 Ozaras et al.36 have reported that NAC
attenuates alcohol-induced liver damage. In their study,
administration of NAC increases glutathione peroxidase
and SOD levels in the liver. We therefore hypothesized
that aerosolized NAC induces the expression of both
MnSOD protein and mRNA in hyperoxic lung injury, in
addition to increasing the GSH level. Our results showed
that NAC increased the protein and mRNA expression
of MnSOD without altering the mRNA expression of
other antioxidant enzymes, including GPx1, CuZnSOD, and
ecSOD.
In summary, our study showed that inhaled NAC induced
both the mRNA and protein expression of MnSOD in
hyperoxic lung injury. It was suggested that the over-
expression of MnSOD is the one of the antioxidative
mechanisms of NAC, apart from its role as a precursor of
GSH. Oxygen is widely used to treat several types of
respiratory insufficiency, but breathing high concentrations
of oxygen carries the risk of exacerbating alveolar injury.
Our results suggest that the clinical use of aerosol NAC may
prevent alveolar damage caused by ROS in patients receiving
oxygen therapy. However, whether inhaled NAC prevents
hyperoxic lung injury must be confirmed clinically before
NAC can be unequivocally recommended.References
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